Terms: = Kidney tumors AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Clinical Outcome
4 results:
1. Renal Epithelioid Angiomyolipoma Undergoing Aggressive clinical outcome: The mdm2 Expression in Tumor Cells of Two Cases.
Inoue C; Saito R; Nakanishi W; Kumata H; Eba S; Fujishima F; Watanabe M; Sasano H
Tohoku J Exp Med; 2019 Feb; 247(2):119-127. PubMed ID: 30799331
[TBL] [Abstract] [Full Text] [Related]
2. clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
[TBL] [Abstract] [Full Text] [Related]
3. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway.
Morimitsu Y; Nakajima M; Hisaoka M; Hashimoto H
APMIS; 2000 Sep; 108(9):617-25. PubMed ID: 11110050
[TBL] [Abstract] [Full Text] [Related]
4. mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters.
Haitel A; Wiener HG; Baethge U; Marberger M; Susani M
Clin Cancer Res; 2000 May; 6(5):1840-4. PubMed ID: 10815906
[TBL] [Abstract] [Full Text] [Related]
